The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival (OS) and stem cell transplant (SCT) in patients with FLT3 mutations treated with CPX-351 versus 7+3: Subgroup analysis of a phase III study of older adults with newly diagnosed, high-risk acute myeloid leukemia (AML).
 
Bruno C. Medeiros
Honoraria - Amgen; Astellas Pharma; Jazz Pharmaceuticals
Consulting or Advisory Role - Amgen; Astellas Pharma; Celator; Celgene; Jazz Pharmaceuticals; Novartis; Pfizer; Roche/Genentech
Research Funding - Astellas Pharma; Celator; Celgene; MEI Pharma; Merck/Schering Plough; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Astellas Pharma; Celator; Celgene; Jazz Pharmaceuticals; Novartis
 
Donna Hogge
No Relationships to Disclose
 
Laura F. Newell
No Relationships to Disclose
 
Dale L. Bixby
No Relationships to Disclose
 
Scott R. Solomon
No Relationships to Disclose
 
Stephen Anthony Strickland
Honoraria - Astellas Pharma
Consulting or Advisory Role - Alexion Pharmaceuticals; Baxalta; Boehringer Ingelheim; CTI; Sunesis Pharmaceuticals; Tolero Pharmaceuticals
Research Funding - Boehringer Ingelheim; Sunesis Pharmaceuticals
 
Tara L. Lin
No Relationships to Disclose
 
Harry Paul Erba
Consulting or Advisory Role - Amgen; Celator/Jazz; Celgene; Daiichi Sankyo; ImmunoGen; Incyte; Millennium; Novartis; Ono Pharmaceutical; Pfizer; Seagen
Speakers' Bureau - Celgene; Incyte; Novartis
Research Funding - Agios (Inst); Amgen (Inst); Astellas Pharma (Inst); Celator (Inst); Daiichi Sankyo (Inst); ImmunoGen (Inst); Janssen (Inst); Juno Therapeutics (Inst); Millennium (Inst)
Other Relationship - GlycoMimetics
 
Bayard L. Powell
Consulting or Advisory Role - Novartis
Speakers' Bureau - Celgene
Research Funding - Celator; Incyte; Novartis; Pfizer; Sunesis Pharmaceuticals
Travel, Accommodations, Expenses - Celgene; Novartis
 
Nikolai Alexandrovich Podoltsev
Consulting or Advisory Role - Alexion Pharmaceuticals; CTI
Research Funding - Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Celator (Inst); Daiichi Sankyo (Inst); Pfizer (Inst); Sunesis Pharmaceuticals (Inst)
 
Robert Ryan
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Michael Chiarella
Employment - Celator; Jazz Pharmaceuticals
Stock and Other Ownership Interests - Celator; Jazz Pharmaceuticals
 
Arthur Louie
Employment - Jazz Pharmaceuticals
Leadership - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Celator; Jazz Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Celator
 
Jeffrey E. Lancet
Consulting or Advisory Role - Asterias Biotherapeutics; Baxalta; Bio-Path Holdings, Inc; Biosight; Boehringer Ingelheim; Celator; Celgene; ERYTECH Pharma; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Novartis
Research Funding - Pfizer (Inst)